The current theory suggesting that TB may have anti‐obesity effects is mainly based on its stimulating impact on peroxisome proliferator‐activated receptor gamma coactivator (PGC)‐1α. This evidence concerns the gene PPARGC1A and obesity due to melanocortin 4 receptor deficiency.